Alivus Life Sciences Limited (NSE:ALIVUS)
India
· Delayed Price · Currency is INR 1,033.60
+5.50 (0.53%)
At close: Apr 24, 2025
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 126.65 billion as of April 24, 2025. Its market cap has increased by 29.70% in one year.
Market Cap
126.65B
Enterprise Value
122.35B
Revenue
22.74B
Ranking
n/a
PE Ratio
28.76
Stock Price
1,033.60
Market Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 126.65B, an increase of 38.10%. That is a compound annual growth rate of 9.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 126.65B | 5.10% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,192.60B |
| Divi's Laboratories | 1,569.32B |
| Cipla | 1,234.20B |
| Mankind Pharma | 1,067.92B |
| Apollo Hospitals Enterprise | 1,019.22B |
| Zydus Lifesciences | 850.62B |
| Aurobindo Pharma | 697.66B |
| Alkem Laboratories | 599.45B |